JP2010051327A - Method for screening organic coloring compound for receptor potential inducer - Google Patents

Method for screening organic coloring compound for receptor potential inducer Download PDF

Info

Publication number
JP2010051327A
JP2010051327A JP2009279089A JP2009279089A JP2010051327A JP 2010051327 A JP2010051327 A JP 2010051327A JP 2009279089 A JP2009279089 A JP 2009279089A JP 2009279089 A JP2009279089 A JP 2009279089A JP 2010051327 A JP2010051327 A JP 2010051327A
Authority
JP
Japan
Prior art keywords
receptor potential
group
organic dye
optic nerve
dye compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009279089A
Other languages
Japanese (ja)
Other versions
JP5090431B2 (en
Inventor
Toshihiko Matsuo
俊彦 松尾
Yasubumi Dano
保文 段王
Sadaji Suga
貞治 菅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Biochemical Laboratories Co Ltd
Priority to JP2009279089A priority Critical patent/JP5090431B2/en
Publication of JP2010051327A publication Critical patent/JP2010051327A/en
Application granted granted Critical
Publication of JP5090431B2 publication Critical patent/JP5090431B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for screening organic coloring compounds for receptor potential inducer which induce a receptor potential responding to light stimulation in the optic nerve, and the use thereof. <P>SOLUTION: The method for screening organic coloring compounds for receptor potential inducer which induce the receptor potential responding to light stimulation in the optic nerve by using culturing systems culturing retinal cells of incubation in a culture medium containing fluorescent calcium indicator in the presence of calcium ion and absence of calcicludine. <P>COPYRIGHT: (C)2010,JPO&INPIT

Description

この発明は、視神経において、光刺激に応じた受容器電位を誘発する、受容器電位誘発剤のための有機色素化合物のスクリーニング方法とその用途に関するものである。   The present invention relates to a method for screening an organic dye compound for a receptor potential inducer that induces a receptor potential in response to light stimulation in the optic nerve and its use.

周知のとおり、視覚は、目が光刺激を電気エネルギーに変換し、脳がその色や形を識別し、判断することによって成立する。目に入った光刺激は網膜において電気エネルギーに変換され、視細胞にある受容器の閾値を超える光刺激が網膜上に結像すると、視神経に受容器電位が誘発され、インパルスの形で上位中枢へ伝達される。視覚が成立するうえで、光刺激を電気エネルギーに変換する網膜の機能は極めて重要であり、網膜が傷病などによって障害を受けると、視野狭窄、視力低下、夜盲などの視覚障害を招来することとなる。   As is well known, vision is established by the eyes converting light stimuli into electrical energy and the brain identifying and judging their color and shape. The light stimulus that enters the eye is converted into electrical energy in the retina, and when a light stimulus that exceeds the threshold of the receptor in the photoreceptor cell is imaged on the retina, a receptor potential is induced in the optic nerve, and the upper center in the form of an impulse. Is transmitted to. The function of the retina that converts light stimuli into electrical energy is extremely important for the establishment of vision, and if the retina is damaged by a disease or the like, it may cause visual impairment such as narrowing of the visual field, decreased visual acuity, and night blindness. Become.

現在、我国においては、網膜の障害による視野狭窄、視力低下、夜盲などの視覚障害に悩む患者が数百万人いると言われている。網膜障害の原因は網膜色素変性症、加齢黄斑変性症、糖尿病網膜症などの疾患によることが多く、例えば、厚生労働省が「特定疾患」に指定している、いわゆる、「難病」の一つである網膜色素変性症の場合、先天的素因により視細胞が変性して視野暗点を招来し、これが徐々に進行して失明にいたる。ただし、網膜がなんらかの障害を被ったとしても、例えば、網膜色素変性症などのように、傷害が視細胞に止まり、視神経が実質的に健常である場合には、光刺激を電気信号に変換し、視神経へ伝達する仕組みを人為的に設けることによって、視覚が完全には回復しないまでも、視野が明るくなり、いわゆる、「生活の質」が改善されるものと期待される。   At present, it is said that there are millions of patients suffering from visual impairment such as visual field stenosis, visual acuity reduction, and night blindness due to retinal damage. The cause of retinal disorders is often due to diseases such as retinitis pigmentosa, age-related macular degeneration, diabetic retinopathy, etc., for example, one of the so-called “intractable diseases” that the Ministry of Health, Labor and Welfare has designated as “specific diseases” In the case of retinal pigment degeneration, the photoreceptor cells degenerate due to a congenital predisposition and cause a dark spot in the visual field, which gradually progresses to blindness. However, even if the retina suffers some kind of damage, for example, when the injury stops in the photoreceptor and the optic nerve is substantially healthy, such as retinitis pigmentosa, the light stimulus is converted into an electrical signal. By artificially providing a mechanism for transmission to the optic nerve, it is expected that the visual field will be brightened and the so-called “quality of life” will be improved even if vision is not completely restored.

現在、斯界においては、電荷結合素子(CCD)などの光電変換素子を主体とする光センサーをチップ状に形成し、これを眼球内外へ取り付けることによって、網膜の障害に起因する視覚障害を克服しようとする、いわゆる、「人工網膜」などの網膜代替用材の研究が鋭意進められている(例えば、特許文献1及び特許文献2を参照)。しかしながら、これまでに提案されている人工網膜は、光センサーや、光センサーを駆動するための外部電源の小型化が難しいことから、実際に眼球内へ挿入して用い得るものが開発されるまでには、今後、幾多の困難を解消しなければならないものと推定される。   Currently, in this field, let's overcome the visual disturbance caused by retinal damage by forming a photosensor mainly composed of photoelectric conversion elements such as charge-coupled devices (CCD) into a chip shape and attaching it to the inside and outside of the eyeball. In other words, research on substitute materials for retina such as so-called “artificial retina” has been advanced (see, for example, Patent Document 1 and Patent Document 2). However, the artificial retina proposed so far is difficult to reduce the size of the optical sensor and the external power source for driving the optical sensor. Therefore, it is estimated that many difficulties must be resolved in the future.

特表平8−511697号公報Japanese National Patent Publication No. 8-511697 特表平11−506662号公報Japanese National Patent Publication No. 11-506661

斯かる状況に鑑み、この発明の課題は、視神経において、光刺激に応じた受容器電位を誘発する、受容器電位誘発剤のための有機色素化合物のスクリーニング方法とその用途にあり、視神経において、光刺激に応じた受容器電位を効果的に誘発し得る有機化学材料とその用途を提供することにある。   In view of such a situation, an object of the present invention is to screen an organic dye compound for a receptor potential inducer that induces a receptor potential in response to light stimulation in the optic nerve and its use. An organic chemical material capable of effectively inducing a receptor potential in response to light stimulation and an application thereof.

本発明者が吸光性有機色素化合物に着目し、鋭意研究し、検索した結果、ポリメチン系色素をはじめとする吸光性有機色素化合物のあるものは、動物の視神経、とりわけ、視神経を構成する網膜神経細胞において、光刺激に応じた受容器電位を誘発するという従来未知の全く新規な知見に到達した。そして、斯かる有機色素化合物を含んでなる受容器電位誘発剤は、網膜代替用材において、視覚関連物質を代替する材料として有利に用い得ることを見出した。   As a result of the present inventor paying attention to the light-absorbing organic dye compound, intensively researched and searched, some of the light-absorbing organic dye compounds including polymethine dyes are the optic nerve of animals, particularly the retinal nerve constituting the optic nerve. We have reached a completely new and unknown finding that induces a receptor potential in response to light stimulation in cells. Then, it has been found that the receptor potential inducer comprising such an organic dye compound can be advantageously used as a material for substituting a visual related substance in a retina replacement material.

すなわち、この発明は、、視神経において、光刺激に応じた受容器電位を誘発する、受容器電位誘発剤のための有機色素化合物のスクリーニング方法を提供することにあり、視神経において、光刺激に応じた受容器電位を誘発する有機色素化合物を含んでなる受容器電位誘発剤を提供することによって前記課題を解決するものである。   That is, the present invention is to provide a screening method for an organic dye compound for a receptor potential inducer that induces a receptor potential in response to light stimulation in the optic nerve, and in response to light stimulation in the optic nerve. The above-mentioned problems are solved by providing a receptor potential inducer comprising an organic dye compound that induces a receptor potential.

さらに、この発明は、斯かる受容器電位誘発剤を用いる網膜代替用材を提供することによって前記課題を解決するものである。   Furthermore, this invention solves the said subject by providing the retinal substitute material using such a receptor potential inducer.

この発明は、諸種の吸光性有機色素化合物のなかに、視神経において、光刺激に応じた受容器電位を誘発するものがあるという独自の知見に基づくものである。斯かる有機色素化合物を含んでなるこの発明の受容器電位誘発剤は、傷病に伴う網膜の障害に起因する視野狭窄、視力低下、夜盲などの視覚障害や、薬物中毒、視覚中枢の神経障害、網膜の疾患、特定の錘体の欠如に起因する色覚異常を緩和したり解消するための人工網膜をはじめとする網膜代替用材において、視覚関連物質を代替する材料として極めて有用である。   The present invention is based on the unique finding that among various types of light-absorbing organic dye compounds, there are those that induce a receptor potential in response to light stimulation in the optic nerve. The receptor potential inducer of the present invention comprising such an organic dye compound is a visual disorder such as visual field stenosis, visual acuity, night blindness caused by injury of the retina due to injury and disease, drug addiction, neurological disorder of visual center, It is extremely useful as a material to replace visual-related substances in retinal replacement materials such as artificial retina for relieving or eliminating color vision abnormalities caused by retinal diseases and lack of specific pyramidal bodies.

この発明でいう有機色素化合物とは、視神経において、光刺激に応じた受容器電位を誘発する有機化合物全般、とりわけ、可視領域に吸収極大を有し、可視光が入射すると、視神経、特に、視神経を構成する網膜神経細胞において、光刺激に応じた受容器電位を誘発する有機色素化合物を意味するものとする。いかなる構造の有機色素化合物であろうとも、それが、可視光に対する吸光能を具備し、かつ、視神経において、光刺激に応じた受容器電位を誘発するものであるかぎり、この発明において有利に用いることができる。斯かる有機色素化合物の具体例としては、可視領域における青色域、緑色域及び/又は赤色域の光を吸収する、例えば、アクリジン系、アザアヌレン系、アゾ系、アントラキノン系、インジゴ系、インダンスレン系、オキサジン系、キサンテン系、クマリン系、ジオキサジン系、チアジン系、チオインジゴ系、テトラポルフィラジン系、トリフェニルメタン系、トリフェノチアジン系、ナフトキノン系、フタロシアニン系、ベンゾキノン系、ベンゾピラン系、ベンゾフラノン系、ポリメチン系、ポルフィリン系及びローダミン系のものが挙げられる。   The organic dye compound as used in the present invention is an organic compound that induces a receptor potential in response to light stimulation in the optic nerve, in particular, has an absorption maximum in the visible region, and when visible light enters, the optic nerve, particularly the optic nerve. An organic pigment compound that induces a receptor potential in response to light stimulation in the retinal neuronal cells constituting the above. Any organic dye compound of any structure is advantageously used in the present invention as long as it has a light-absorbing ability for visible light and induces a receptor potential in response to light stimulation in the optic nerve. be able to. Specific examples of such organic dye compounds absorb light in the blue, green and / or red range in the visible range, for example, acridine, azaannulene, azo, anthraquinone, indigo, indanthrene. , Oxazine, xanthene, coumarin, dioxazine, thiazine, thioindigo, tetraporphyrazine, triphenylmethane, triphenothiazine, naphthoquinone, phthalocyanine, benzoquinone, benzopyran, benzofuranone, polymethine System, porphyrin series and rhodamine series.

好ましい有機色素化合物としては、メチル基、エチル基、プロピル基、イソプロピル基などの脂肪族炭化水素基、シクロプロピル基、シクロブチル基、シクロペンチル基、クロヘキシル基、シクロヘキセニル基などの脂環式炭化水素基、フェニル基、ビフェニリル基などの芳香族炭化水素基、フルオロ基、クロロ基、ブロモ基、ヨード基などのハロゲン基などによる置換基を1又は複数有することあるジメチン鎖、トリメチン鎖、テトラメチン鎖、ペンタメチン鎖、ヘキサメチン鎖、へプタメチン鎖などのポリメチン鎖の両端に、例えば、メチル基、エチル基、プロピル基、イソプロピル基、1−プロペニル基、2−プロペニル基、ブチル基、イソブチル基、sec−ブチル基、tert−ブチル基、2−ブテニル基、1,3−ブタジエニル基、ペンチル基、イソペンチル基、ネオペンチル基、tert−ペンチル基、1−メチルペンチル基、2−メチルペンチル基、2−ペンテニル基、ヘキシル基、イソヘキシル基などの脂肪族炭化水素基、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基などの脂環式炭化水素基、フェニル基などの芳香族炭化水素基、メトキシ基、エトキシ基、プロポキシ基などのエーテル基、アセトキシ基、ベンゾイルオキシ基、メトキシカルボニル基、エトキシカルボニル基、プロポキシカルボニル基などのエステル基、メチルアミノ基、ジメチルアミノ基、エチルアミノ基、ジエチルアミノ基、プロピルアミノ基、ジプロピルアミノ基、ブチルアミノ基、ジブチルアミノ基などのアミノ基、ヒドロキシ基、カルボキシ基、スルホ基、ニトロ基、シアノ基、さらには、それらの組合わせによる置換基を1又は複数有することある、互いに同じか異なるイミダゾール環、インダンジオン環、インドレニン環、オキサゾール環、キノリン環、セレナゾール環、チアゾリン環、チアゾール環、チオオキサゾリドン環、チオナフテン環、チオバルビツール酸環、チオヒダントイン環、ナフトオキサゾール環、ナフトセレナゾール環、ナフトチアゾール環、ピラゾロン環、ピリジン環、ベンゾイミダゾール環、ベンゾインドレニン環、ベンゾオキサゾール環、ベンゾセレナゾール環、ベンゾチアゾール環、ロダニン環などの環状核が結合してなる、例えば、オキソノール色素、シアニン色素、スチリル色素、メロシアニン色素、ロダシアニン色素などのポリメチン系の有機色素化合物が挙げられ、これらのうちで、可視領域における青色域、緑色域及び/又は赤色域の光を吸収するものが特に好ましい。ポリメチン系有機色素化合物における対イオンとしては、例えば、塩素イオン、臭素イオン、沃素イオンなどの陰イオンや、アンモニウムイオン、トリメチルアンモニウムイオン、トリエチルアンモニウムイオンなどの陽イオンから選択され、分子内に陰又は陽に荷電する置換基を有する場合には、見掛け上、対イオンを有しない。   Preferred organic dye compounds include aliphatic hydrocarbon groups such as methyl group, ethyl group, propyl group, and isopropyl group, and alicyclic hydrocarbon groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, and cyclohexenyl group. A dimethine chain, a trimethine chain, a tetramethine chain, or a pentamethine that may have one or more substituents such as an aromatic hydrocarbon group such as a phenyl group or a biphenylyl group, a halogen group such as a fluoro group, a chloro group, a bromo group, or an iodo group For example, a methyl group, an ethyl group, a propyl group, an isopropyl group, a 1-propenyl group, a 2-propenyl group, a butyl group, an isobutyl group, or a sec-butyl group at both ends of a polymethine chain such as a chain, a hexamethine chain, or a heptamethine chain. , Tert-butyl group, 2-butenyl group, 1,3-butadienyl , Pentyl group, isopentyl group, neopentyl group, tert-pentyl group, 1-methylpentyl group, 2-methylpentyl group, 2-pentenyl group, hexyl group, isohexyl group and other aliphatic hydrocarbon groups, cyclopropyl group, cyclobutyl Group, cycloaliphatic hydrocarbon group such as cyclopentyl group and cyclohexyl group, aromatic hydrocarbon group such as phenyl group, ether group such as methoxy group, ethoxy group and propoxy group, acetoxy group, benzoyloxy group, methoxycarbonyl group, Ester groups such as ethoxycarbonyl group and propoxycarbonyl group, amino groups such as methylamino group, dimethylamino group, ethylamino group, diethylamino group, propylamino group, dipropylamino group, butylamino group and dibutylamino group, hydroxy group Carboxy group An imidazole ring, an indandione ring, an indolenine ring, an oxazole ring, a quinoline ring, a selenazole ring, which may have one or more substituents by a group, a nitro group, a cyano group, or a combination thereof, Thiazoline ring, thiazole ring, thiooxazolidone ring, thionaphthene ring, thiobarbituric acid ring, thiohydantoin ring, naphthoxazole ring, naphthselenazole ring, naphthothiazole ring, pyrazolone ring, pyridine ring, benzimidazole ring, benzoindolenin ring , Benzoxazole rings, benzoselenazole rings, benzothiazole rings, rhodanine rings, and other polynuclear organic dye compounds such as oxonol dyes, cyanine dyes, styryl dyes, merocyanine dyes, rhodacyanine dyes The thing which absorbs the light of the blue region in a visible region, a green region, and / or a red region among these is especially preferable among these. The counter ion in the polymethine organic dye compound is selected from, for example, anions such as chlorine ion, bromine ion and iodine ion, and cations such as ammonium ion, trimethylammonium ion and triethylammonium ion. When it has a positively charged substituent, it apparently has no counter ion.

斯かる有機色素化合物の具体例としては、例えば、化学式1乃至化学式17で表されるものが挙げられる。生体における光電変換過程は、光刺激による視物質のシス−トランス異性化を経由していると言われており、公知の網膜代替用材においても、光刺激によってシス−トランス異性化する化合物を採用する試みがあるけれども、上記した有機色素化合物は、いずれも、光照射してもシス−トランス異性化を招来することがない。この発明は、光照射によってシス−トランス異性化しない化合物であっても、網膜代替用材として用い得ることを明らかにするものである。   Specific examples of such organic dye compounds include those represented by Chemical Formulas 1 to 17. It is said that the photoelectric conversion process in the living body is via cis-trans isomerization of visual substances by light stimulation, and a compound that cis-trans isomerizes by light stimulation is also adopted in known retinal substitute materials. Although there are attempts, none of the above organic dye compounds cause cis-trans isomerization even when irradiated with light. The present invention makes it clear that even a compound that is not cis-trans isomerized by light irradiation can be used as a retina replacement material.

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

Figure 2010051327
Figure 2010051327

ちなみに、斯かるポリメチン系の有機色素化合物は、いずれも、例えば、速水正明監修、『感光色素』、産業図書株式会社、1997年10月17日発行、11乃至31頁に記載された方法か、それらの方法に準じて所望量を得ることができる。市販品がある場合には、必要に応じて、それを精製して用いればよい。また、有機色素化合物が、視神経において、光刺激に応じた受容器電位を誘発する性質を具備するかどうかは、例えば、一戸裕子編集、『実験医学』、1989年4月5日、株式会社羊土社発行、第7巻、第6号に記載された細胞内カルシウム実験法に準じて、蛍光カルシウム指示薬を含有する培養液中で動物の網膜細胞を培養する際、有機色素化合物を培養液中に共存させたときに指示薬から放出される蛍光の強度や細胞内に発生する電位を調べることによって判定することができる。   Incidentally, any of such polymethine organic dye compounds is, for example, a method described in the supervision of Masaaki Hayami, “Photosensitive Dye”, Sangyo Tosho Co., Ltd., published on October 17, 1997, pages 11 to 31; A desired amount can be obtained according to these methods. If there is a commercial product, it may be purified and used as necessary. Whether or not an organic dye compound has a property of inducing a receptor potential in response to light stimulation in the optic nerve is determined by, for example, Yuko Ichinohe, “Experimental Medicine”, April 5, 1989, Sheep Co., Ltd. When cultivating animal retinal cells in a culture solution containing a fluorescent calcium indicator according to the intracellular calcium experiment method described in Satosha, Vol. 7, No. 6, the organic dye compound is added to the culture solution. It can be determined by examining the intensity of the fluorescence emitted from the indicator and the potential generated in the cell.

この発明でいう受容器電位誘発剤とは、用途に応じた斯かる有機色素化合物の1又は複数を含んでなるものである。ただし、この発明の受容器電位誘発剤は、発明の目的を逸脱しない範囲で、斯かる有機色素化合物の1又は複数とともに、用途に応じたそれ以外の、例えば、眼科用剤、賦形剤、溶解剤、安定化剤、抗酸化剤、その他の調製用剤の1又は複数を含んでいてもよい。用途にもよるけれども、この発明の受容器電位誘発剤を網膜代替用材として、例えば、視覚障害や色覚異常の患者へ適用する場合には、可視領域に吸収極大を有し、かつ、吸収極大波長が互いに相違する複数の有機色素化合物を組み合わせることによって、受容器電位誘発剤の主体となる有機色素化合物が、全体として、全可視領域に亙って吸光能を発揮するようにするのが望ましい。   The receptor potential inducer as referred to in the present invention comprises one or more of such organic dye compounds depending on the application. However, the receptor potential inducer of the present invention is not limited to the purpose of the invention, and one or a plurality of such organic dye compounds, and other, for example, ophthalmic agents, excipients, One or more of a solubilizer, a stabilizer, an antioxidant, and other preparation agents may be included. Although it depends on the application, when the receptor potential inducer of the present invention is applied as a retina substitute material to, for example, a patient with visual impairment or color blindness, it has an absorption maximum in the visible region and has an absorption maximum wavelength. By combining a plurality of organic dye compounds having different from each other, it is desirable that the organic dye compound as a main component of the receptor potential inducer exhibits a light absorbing ability over the entire visible region as a whole.

この発明の受容器電位誘発剤の用途について説明すると、既述したとおり、この発明で用いる有機色素化合物は、視神経において、光刺激に応じた受容器電位を誘発する性質を具備することから、傷病などによる視覚傷害や、傷病若しくは先天的素因による色覚異常を緩和したり解消するための網膜代替用材を作製するための材料、とりわけ、視覚関連物質を代替するための材料として極めて有用である。   The use of the receptor potential inducer of the present invention will be described. As described above, the organic dye compound used in the present invention has a property of inducing a receptor potential in response to light stimulation in the optic nerve. It is extremely useful as a material for producing a retinal replacement material for alleviating or eliminating color injuries caused by the above-mentioned visual injuries or sickness or a congenital predisposing factor, particularly a material for substituting a visual related substance.

この発明でいう網膜代替用材とは、人をはじめとする動物の網膜の一部又は全体の機能を代替し得る人工材料を意味するものとする。具体的には、視覚関連物質の代替物として、この発明の受容器電位誘発剤を薬理学的に許容し得る、例えば、水、エタノール、ジメチルスルホキシド若しくはそれらの混液などの溶剤を用いて溶液の形態となし、これを注射などによって眼球内へ導入するもの、さらには、受容器電位誘発材の主体となる有機色素化合物を不溶性の基材へ付着させた形態となし、これを外科術などによって眼球内へ導入し、網膜表面へ移植する、一種の「人工網膜」ともいうべきものが挙げられる。   The retinal substitute material in the present invention means an artificial material that can substitute a part or the whole function of the retina of an animal including a human. Specifically, as a substitute for a visual related substance, the receptor potential inducer of the present invention is pharmacologically acceptable, for example, using a solvent such as water, ethanol, dimethyl sulfoxide or a mixture thereof to Forms, which are introduced into the eyeball by injection or the like, and further, forms in which an organic pigment compound that is the main component of the receptor potential inducer is attached to an insoluble substrate, which is treated by surgery or the like. There is a kind of “artificial retina” that is introduced into the eyeball and transplanted to the surface of the retina.

前者の形態のものとしては、例えば、網膜における受容器に特異的なリガンドを有機色素化合物へ化学的に結合せしめ、これを溶液の形態で眼球内へ注射することによって、有機色素化合物を網膜の表面へ特異的に結合させるものが挙げられる。この場合、受容器に特異的なリガンドとしては、例えば、視覚関連物質、チャネル蛋白質に対する受容器蛋白質若しくは抗体、受容器蛋白質に対する抗体、膜蛋白質に対する抗体、さらには、それらのフラグメントなどが挙げられる。   In the former form, for example, a ligand specific to a receptor in the retina is chemically bound to the organic dye compound, and this is injected into the eyeball in the form of a solution, whereby the organic dye compound is injected into the retina. Those specifically bound to the surface can be mentioned. In this case, the ligand specific to the receptor includes, for example, a visual-related substance, a receptor protein or antibody against a channel protein, an antibody against the receptor protein, an antibody against a membrane protein, and fragments thereof.

後者の形態のものとしては、例えば、眼杯や患部の形状、大きさに応じたフィルム状、シート状、ネット状などの適宜形状に形成した生体適合高分子を基材に用い、有機色素化合物が眼球内液へ実質的に接触するようにその一側又は両側へこの発明の受容器電位誘発剤を化学的に結合させたものや、この発明の受容器電位誘発剤を含有せしめた生体適合高分子を上記のごとき形状、大きさのフィルム状、シート状、ネット状に形成したものが挙げられる。   As the latter form, for example, a biocompatible polymer formed in an appropriate shape such as a film shape, a sheet shape, or a net shape according to the shape and size of the eye cup or affected area is used as a base material, and an organic dye compound A biocompatibility in which the receptor potential inducer of the present invention is chemically bonded to one side or both sides thereof so as to substantially contact the intraocular fluid, or the receptor potential inducer of the present invention is contained. Examples include polymers formed in the above-described shape, size film shape, sheet shape, and net shape.

基材となる生体適合高分子としては、適度の親水性、剛性及び柔軟性を有し、かつ、全可視領域に亙って実質的に透明であって、生体内の酵素や磨耗に耐性を有するものであれば特に制限はない。個々の生体適合高分子としては、眼球内移植などに用いられる、例えば、コラーゲン、ゼラチン、セルロース、ヒアルロン酸などの天然高分子、デキストラン、セルロース、プルラン、ヘパリンの架橋物、誘導体などの半合成高分子、シリコーン系、ポリアクリルアミド系、ポリアクリルニトリル系、ポリアクリレート系、ポリウレア系、ポリウレタン系、ポリエステル系、ポリエチレン系、ポリエチレンオキシド系、ポリエチレングリコール系、ポリカーボネート系、ポリカルバメート系、ポリ酢酸ビニル系、ポリヒドロキシアルキルメタクリレート系、ポリビニルアルコール系、ポリビニルピロリドン系、ポリメタクリレート系の重合体及び共重合体をはじめとする合成高分子、さらには、それらの複合物が挙げられる。有機色素化合物を結合させた基材を網膜表面へ移植するに当たって、網膜が基材における有機色素化合物を結合させていない面と接触する場合には、基材として電気伝導性を有する生体適合高分子を選択して用いるのが望ましい。   The biocompatible polymer used as a base material has moderate hydrophilicity, rigidity, and flexibility, and is substantially transparent over the entire visible range, and is resistant to in vivo enzymes and wear. If it has, there will be no restriction | limiting in particular. Examples of individual biocompatible polymers include semi-synthetic polymers such as natural polymers such as collagen, gelatin, cellulose, and hyaluronic acid, cross-linked products and derivatives of dextran, cellulose, pullulan, heparin, etc. Molecule, silicone, polyacrylamide, polyacrylonitrile, polyacrylate, polyurea, polyurethane, polyester, polyethylene, polyethylene oxide, polyethylene glycol, polycarbonate, polycarbamate, polyvinyl acetate, Examples thereof include synthetic polymers such as polyhydroxyalkyl methacrylate, polyvinyl alcohol, polyvinyl pyrrolidone, and polymethacrylate polymers and copolymers, and composites thereof. When transplanting a substrate to which the organic dye compound is bonded to the surface of the retina, when the retina comes into contact with the surface of the substrate to which the organic dye compound is not bonded, a biocompatible polymer having electrical conductivity as the substrate. It is desirable to select and use.

基材へ受容器電位誘発剤を付着させるには、基材の主体となる高分子と、受容器電位誘発剤の主体となる有機色素化合物とを直接化学反応させるか、あるいは、例えば、アズラクトン基、アミノ基、アルデヒド基、イソシアナート基、エチレンイミノ基、エポキシ基、ケテン基、酸アジド基、酸ヒドラジド基、酸無水物基、スルホン酸基、スルホン酸ハライド基、チオイソシアナート基、ヒドロキサム酸基、ビニル基、メルカプト基、ラクトン基などの活性官能基を複数有する多官能試薬を用いて、生体適合高分子へ有機色素化合物を結合させる方法が挙げられる。   In order to attach the receptor potential inducer to the substrate, the polymer that is the main component of the substrate and the organic dye compound that is the main component of the receptor potential inducer are directly chemically reacted or, for example, an azlactone group , Amino group, aldehyde group, isocyanate group, ethyleneimino group, epoxy group, ketene group, acid azide group, acid hydrazide group, acid anhydride group, sulfonic acid group, sulfonic acid halide group, thioisocyanate group, hydroxamic acid And a method of binding an organic dye compound to a biocompatible polymer using a polyfunctional reagent having a plurality of active functional groups such as a group, a vinyl group, a mercapto group, and a lactone group.

いずれの形態を採用する場合であっても、有機色素化合物を生体へ接触させて用いることに変わりはないことから、毒性が低い有機色素化合物を選別して用いるのが望ましい。有機色素化合物のうちでも、例えば、既述したごときポリメチン系の有機色素化合物は、一般に、細胞毒性などの毒性を有しないか、毒性が極めて微弱であることから、この点においても、この発明を実施するうえで好適である。   Regardless of which form is employed, it is desirable to select and use an organic dye compound having low toxicity since the organic dye compound is used in contact with a living body. Among organic dye compounds, for example, polymethine organic dye compounds as described above generally have no toxicity such as cytotoxicity or are extremely weak in toxicity. It is suitable for implementation.

この発明による網膜代替用材の適用対象としては、例えば、網膜色素変性症、加齢黄斑変性症、糖尿病網膜症などの傷病に伴う視野狭窄、視力低下、夜盲などの視覚障害や、二色型色覚(色盲)、異常三色型色覚(色弱)などの網膜における特定の錘体の欠如や薬物中毒、視覚中枢の神経障害、網膜の疾患などに起因する色覚異常を緩和したり解消するための医療用材として極めて有用である。この発明の受容器電位誘発剤は、光エレクトロニクスなどの医療分野以外の用途において、例えば、制御機器などにおける光センサーを構成する材料としても有用である。   Applicable objects of the retinal replacement material according to the present invention include, for example, visual disturbances such as retinal pigment degeneration, age-related macular degeneration, diabetic retinopathy, visual field stenosis, visual acuity, night blindness, and two-color color vision. Medical treatment to alleviate or eliminate color blindness caused by the absence of specific pyramidal bodies in the retina such as (color blindness), abnormal three-color type color vision (color weakness), drug addiction, visual center neuropathy, retinal diseases, etc. It is extremely useful as a material. The receptor potential inducer of the present invention is useful as a material constituting an optical sensor in, for example, a control device in applications other than the medical field such as optoelectronics.

以下、この発明の実施の形態につき、実施例に基づいて説明する。   Hereinafter, embodiments of the present invention will be described based on examples.

〈受容器電位誘発剤〉
いずれもポリメチン系の有機色素化合物である、表1に示す4種類の化合物につき、一戸裕子編集、『実験医学』、1989年4月5日、株式会社羊土社発行、第7巻、第6号に記載された細胞内カルシウム実験法に準じて受容器電位誘発能の有無を調べた。なお、化学式14乃至化学式17で表される有機色素化合物は、株式会社林原生物化学研究所から、それぞれ、商品名『NK−2761』、『NK−5962』、『NK−3041』及び『NK−3630』で販売されている。
<Receptor potential inducer>
All of the four types of compounds shown in Table 1, which are polymethine-based organic dye compounds, edited by Yuko Ichinohe, “Experimental Medicine”, April 5, 1989, published by Yodosha Co., Ltd., Volumes 7, 6 The presence or absence of the receptor potential induction ability was examined according to the intracellular calcium experiment method described in No. 1. The organic dye compounds represented by Chemical Formula 14 to Chemical Formula 17 are trade names “NK-2761”, “NK-5962”, “NK-3041” and “NK-” from Hayashibara Biochemical Laboratories, Inc., respectively. 3630 ".

Figure 2010051327
Figure 2010051327

孵卵10日目の受精卵を70%(v/v)水性エタノールで殺菌した後、卵殻へ小穴を穿設し、そこから胚を取り出した。胚から眼球を摘出し、中央部で切断し、前半部を硝子体とともに除去した後、網膜を剥離し、0.25%(w/v)トリプシンと1mMエチレンジアミンとを含有する、Ca2+/Mg2+無含有のハンクス緩衝液(pH7.4)に浸漬させて網膜細胞を分散させた。網膜細胞を遠心分離により採取し、ダルベッコ変法イーグル培地(pH7.4)により洗浄した後、10(v/v)仔ウシ血清、0.1mg/mlストレプトマイシン及び0.1mg/mlアンピシリンを補足したダルベッコ変法イーグル培地(pH7.4)を用いて24ウェル培養プレートへ細胞密度6×105個/mlになるように播種し、培地を適宜交換しながら、視神経を構成する網膜神経細胞の成長が優勢になるまで培養した。   After fertilization of the fertilized egg on the 10th day of incubation with 70% (v / v) aqueous ethanol, a small hole was made in the eggshell, and the embryo was taken out therefrom. The eyeball is removed from the embryo, cut at the center, the first half is removed together with the vitreous body, the retina is peeled off, and Ca2 + / Mg2 + containing 0.25% (w / v) trypsin and 1 mM ethylenediamine is contained. Retinal cells were dispersed by immersing in the contained Hanks buffer (pH 7.4). Retinal cells were collected by centrifugation, washed with Dulbecco's modified Eagle's medium (pH 7.4) and supplemented with 10 (v / v) calf serum, 0.1 mg / ml streptomycin and 0.1 mg / ml ampicillin. Using a Dulbecco's modified Eagle's medium (pH 7.4), seeding a 24-well culture plate at a cell density of 6 × 10 5 cells / ml, and replacing the medium as needed, the growth of the retinal neurons constituting the optic nerve Incubate until dominant.

その後、培養プレートにおける各ウェルへ蛍光カルシウム指示薬の1種であるFluo−4 アセトキシメチルエステル(モレキュラー・プローブズ社製造)を10μMになるように加え、37℃で30分間培養した後、Fluo−4 アセトキシメチルエステルを省略した以外は上記と同様にしてさらに30分間培養した。次いで、各ウェルにおける培地を10mM N−2−ヒドロキシエチルピペラジン−N´−2−エタンスルホン酸、145mM塩化ナトリウム、5mM塩化カリウム、10mM塩化マグネシウム、1mM塩化カルシウム及び10mMグルコースを含有する生理食塩水(pH7.4)で置換した後、汎用の細胞内カルシウム顕微測定装置における倒立顕微鏡のステージへ培養プレートを取付けた。そして、培養物に対して、表1に示す有機色素化合物のいずれかをジメチルスルホキシドに溶解し、濃度0.0005乃至0.5μg/mlになるように添加する前後に、波長470乃至490nm付近の光を照射してFluo−4 アセトキシメチルエステルを励起し、Fluo−4 アセトキシメチルエステルから波長510乃至550nm付近に放出される蛍光の強度と細胞内電位をそれぞれ調べた。   Thereafter, Fluo-4 acetoxymethyl ester (produced by Molecular Probes), which is one type of fluorescent calcium indicator, is added to each well of the culture plate so as to be 10 μM, and cultured at 37 ° C. for 30 minutes, and then Fluo-4 acetoxy. The culture was further continued for 30 minutes in the same manner as described above except that the methyl ester was omitted. Next, the medium in each well was treated with physiological saline containing 10 mM N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid, 145 mM sodium chloride, 5 mM potassium chloride, 10 mM magnesium chloride, 1 mM calcium chloride and 10 mM glucose ( After replacement with pH 7.4), the culture plate was attached to the stage of an inverted microscope in a general-purpose intracellular calcium microscopic measurement apparatus. Then, before or after adding any of the organic dye compounds shown in Table 1 to dimethyl sulfoxide and adding the culture to a concentration of 0.0005 to 0.5 μg / ml to the culture, a wavelength around 470 to 490 nm is obtained. The light was irradiated to excite Fluo-4 acetoxymethyl ester, and the intensity of fluorescence emitted from Fluo-4 acetoxymethyl ester at a wavelength of 510 to 550 nm and the intracellular potential were examined.

表1の結果に見られるとおり、試験に供した化学式14乃至化学式17で表される4種類の有機色素化合物は、いずれも、Fluo−4 アセトキシメチルエステルから放出される蛍光の強度を有意に上昇させた。また、化学式14乃至化学式17のいずれかを添加した系においては、顕著な受容器電位が細胞内電位として観察された。ところが、別途、培養液にカルシクルジン(L型、N型及びP型の高閾値カルシウムチャネルに対する拮抗阻害剤)を2.5μM添加した以外は上記と同様に試験したところ、化学式14乃至化学式17のいずれかで表される有機色素化合物の存在下においても、Fluo−4 アセトキシメチルエステルから放出される蛍光の強度は上昇せず、細胞内電位も観察されなかった。   As can be seen from the results in Table 1, each of the four organic dye compounds represented by Chemical Formulas 14 to 17 subjected to the test significantly increased the intensity of fluorescence emitted from Fluo-4 acetoxymethyl ester. I let you. Further, in the system to which any one of the chemical formulas 14 to 17 was added, a remarkable receptor potential was observed as an intracellular potential. However, a test was conducted in the same manner as above except that calcicludine (competitive inhibitor against L-type, N-type and P-type high threshold calcium channels) was added to the culture solution. Even in the presence of the organic dye compound represented by (2), the intensity of fluorescence emitted from Fluo-4 acetoxymethyl ester did not increase, and no intracellular potential was observed.

Fluo−4 アセトキシメチルエステルは、これを神経細胞内へ取り込ませた状態で光照射すると、細胞内へカルシウムイオンが流入したときのみ波長510乃至550nm付近に蛍光を放出する性質がある。視神経において、受容器電位が誘発されると、カルシウムチャネルが開き、細胞内へカルシウムイオンが流入することは周知の事項であることから、化学式14乃至化学式17のいずれかで表される有機色素化合物が共存したときにのみFluo−4 アセトキシメチルエステルの蛍光強度が上昇したことは、それらの有機色素化合物が、視神経において、光刺激に応じた受容器電位を誘発する性質を具備することを物語っており、このことは、カルシクルジンの非存在下において顕著な細胞内電位が観察されたことによっても裏付けられている。   Fluo-4 acetoxymethyl ester has a property of emitting fluorescence at a wavelength of 510 to 550 nm only when calcium ions flow into the cells when irradiated with light in a state of being incorporated into neurons. In the optic nerve, when a receptor potential is induced, it is a well-known matter that a calcium channel opens and calcium ions flow into the cell. Therefore, an organic dye compound represented by any one of Chemical Formulas 14 to 17 The increase in the fluorescence intensity of Fluo-4 acetoxymethyl ester only when the two coexist with each other indicates that these organic dye compounds have the property of inducing a receptor potential in response to light stimulation in the optic nerve. This is supported by the observation of a significant intracellular potential in the absence of calcycludin.

視覚は、ロドプシン、G蛋白質(トランスデューシン)、サイクリックGMP、ホスホジエステラーゼなどの視覚関連物質が自然の摂理にしたがって化学反応することによって、視神経において、光刺激に応じた受容器電位が誘発される過程を経由して成立する。本例の結果は、吸光性有機色素化合物、とりわけ、ポリメチン系の有機色素化合物が、視神経、特に、視神経を構成する網膜神経細胞において、光刺激に応じた受容器電位を誘発する性質を具備するものであることを示している。このことは、斯かる有機色素化合物を含んでなるこの発明の受容器電位誘発剤が、網膜代替用材において、視覚関連物質を代替する材料として有用であることを物語っている。   As for vision, a receptor potential corresponding to light stimulation is induced in the optic nerve by a chemical reaction of visual related substances such as rhodopsin, G protein (transducin), cyclic GMP, and phosphodiesterase according to natural provisions. It is established via a process. As a result of this example, the light-absorbing organic dye compound, particularly, the polymethine organic dye compound has a property of inducing a receptor potential in response to light stimulation in the optic nerve, particularly in the retinal nerve cells constituting the optic nerve. It is a thing. This indicates that the receptor potential inducer of the present invention comprising such an organic dye compound is useful as a material for substituting the visual related substance in the retina replacement material.

以上説明したごとく、この発明は、諸種の吸光性有機色素化合物のなかに、視神経において、光刺激に応じた受容器電位を誘発するものがあるという独自の知見に基づくものである。斯かる有機色素化合物を含んでなるこの発明の受容器電位誘発剤は、傷病に伴う網膜の障害に起因する視野狭窄、視力低下、夜盲などの視覚障害や、薬物中毒、視覚中枢の神経障害、網膜の疾患、特定の錘体の欠如に起因する色覚異常を緩和したり解消するための人工網膜をはじめとする網膜代替用材において、視覚関連物質を代替する材料として極めて有用である。   As described above, the present invention is based on the unique finding that among various types of light-absorbing organic dye compounds, there are those that induce a receptor potential in response to light stimulation in the optic nerve. The receptor potential inducer of the present invention comprising such an organic dye compound is a visual disorder such as visual field stenosis, visual acuity, night blindness caused by injury of the retina due to injury and disease, drug addiction, neurological disorder of visual center, It is extremely useful as a material to replace visual-related substances in retinal replacement materials such as artificial retina for relieving or eliminating color vision abnormalities caused by retinal diseases and lack of specific pyramidal bodies.

斯くも顕著な効果を奏するこの発明は、斯界に貢献すること誠に多大な、意義のある発明であると言える。   It can be said that this invention having such remarkable effects is a very significant invention that contributes to the world.

Claims (2)

同一分子内において、可視領域に吸収極大を与えるエチレン性共役二重結合、芳香性二重結合、及び/又は、アゾ結合を有し、かつ、網膜細胞の維持に好適な水性媒体に対して親和性を示す、イミニウム基、ヒドロシキ基、及び/又は、有機酸基を有するとともに、可視光を吸収する有機色素化合物の中から、視神経において、光刺激に応じた受容器電位を誘発する、受容器電位誘発剤のための有機色素化合物をスクリーニングする方法であって、当該方法は、カルシウムイオン存在下、カルシクルジンの非存在下で、蛍光カルシウム指示薬を含有する培養液中で孵卵の網膜細胞を培養する際、被験有機色素化合物を当該培養液中に共存させて、当該網膜細胞に可視光を照射したとき、光刺激に応じた受容器電位を誘発し、当該網膜細胞内にカルシウムイオンを流入させ、当該網膜細胞内に取り込まれた蛍光カルシウム指示薬から放出される蛍光の強度を上昇させ、かつ、当該被験有機色素化合物が、カルシウムイオン存在下、カルシクルジンの存在下では、蛍光の強度を上昇させないとき、当該被験有機色素化合物が、視神経において、光刺激に応じた受容器電位を誘発する、受容器電位誘発剤のための有機色素化合物であると判定することを特徴とする、視神経において、光刺激に応じた受容器電位を誘発する、受容器電位誘発剤のための有機色素化合物のスクリーニング方法。   In the same molecule, it has an ethylenic conjugated double bond, an aromatic double bond and / or an azo bond that give an absorption maximum in the visible region, and has an affinity for an aqueous medium suitable for maintaining retinal cells Receptor having an iminium group, a hydroxy group, and / or an organic acid group that exhibits sex, and induces a receptor potential in response to light stimulation in the optic nerve among organic pigment compounds that absorb visible light A method for screening an organic dye compound for an electric potential inducer, wherein the method comprises culturing cultured retinal cells in a culture solution containing a fluorescent calcium indicator in the presence of calcium ions and in the absence of calcicludine. In this case, when the test organic pigment compound is coexisted in the culture solution and the retinal cells are irradiated with visible light, a receptor potential corresponding to the light stimulus is induced, The intensities of fluorescence emitted from the fluorescent calcium indicator incorporated into the retinal cells are increased by injecting lucium ions, and the test organic dye compound is fluorescent in the presence of calcium ions and calcicludine. When the intensity is not increased, the test organic pigment compound is determined to be an organic pigment compound for a receptor potential inducer that induces a receptor potential in response to light stimulation in the optic nerve, A screening method for an organic dye compound for a receptor potential inducer that induces a receptor potential in response to light stimulation in the optic nerve. 請求項1に記載のスクリーニング方法により、視神経において、光刺激に応じた受容器電位を誘発する、受容器電位誘発剤のための有機色素化合物であると判定された有機色素化合物を結合させた、コラーゲン、ゼラチン、セルロース、ヒアルロン酸;デキストラン、セルロース、プルラン、ヘパリンの架橋物;及びシリコーン系、ポリアクリルアミド系、ポリアクリルニトリル系、ポリアクリレート系、ポリウレア系、ポリウレタン系、ポリエステル系、ポリエチレン系、ポリエチレンオキシド系、ポリエチレングリコール系、ポリカーボネート系、ポリカルバメート系、ポリ酢酸ビニル系、ポリヒドロキシアルキルメタクリレート系、ポリビニルアルコール系、ポリビニルピロリドン系、ポリメタクリレート系の重合体及び共重合体から選ばれる生体適合高分子。   According to the screening method of claim 1, in the optic nerve, an organic dye compound determined to be an organic dye compound for a receptor potential inducer that induces a receptor potential in response to light stimulation is bound. Collagen, gelatin, cellulose, hyaluronic acid; cross-linked dextran, cellulose, pullulan, heparin; and silicone, polyacrylamide, polyacrylonitrile, polyacrylate, polyurea, polyurethane, polyester, polyethylene, poly From ethylene oxide, polyethylene glycol, polycarbonate, polycarbamate, polyvinyl acetate, polyhydroxyalkyl methacrylate, polyvinyl alcohol, polyvinyl pyrrolidone, polymethacrylate polymers and copolymers Bareru biocompatible polymer.
JP2009279089A 2009-12-09 2009-12-09 Screening method for organic dye compounds for receptor potential inducers Expired - Fee Related JP5090431B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009279089A JP5090431B2 (en) 2009-12-09 2009-12-09 Screening method for organic dye compounds for receptor potential inducers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009279089A JP5090431B2 (en) 2009-12-09 2009-12-09 Screening method for organic dye compounds for receptor potential inducers

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002285784A Division JP2004121292A (en) 2002-09-30 2002-09-30 Receptor potential inducer

Publications (2)

Publication Number Publication Date
JP2010051327A true JP2010051327A (en) 2010-03-11
JP5090431B2 JP5090431B2 (en) 2012-12-05

Family

ID=42067898

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009279089A Expired - Fee Related JP5090431B2 (en) 2009-12-09 2009-12-09 Screening method for organic dye compounds for receptor potential inducers

Country Status (1)

Country Link
JP (1) JP5090431B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10568839B2 (en) 2011-01-11 2020-02-25 Capsugel Belgium Nv Hard capsules
US11319566B2 (en) 2017-04-14 2022-05-03 Capsugel Belgium Nv Process for making pullulan
US11576870B2 (en) 2017-04-14 2023-02-14 Capsugel Belgium Nv Pullulan capsules

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51122389A (en) * 1975-04-02 1976-10-26 Exxon Research Engineering Co Photoelectric device
JPS53131782A (en) * 1977-04-20 1978-11-16 Exxon Research Engineering Co Photoelectric device
JPS56130976A (en) * 1980-03-17 1981-10-14 Agency Of Ind Science & Technol Photoelectric converter

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51122389A (en) * 1975-04-02 1976-10-26 Exxon Research Engineering Co Photoelectric device
JPS53131782A (en) * 1977-04-20 1978-11-16 Exxon Research Engineering Co Photoelectric device
JPS56130976A (en) * 1980-03-17 1981-10-14 Agency Of Ind Science & Technol Photoelectric converter

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10568839B2 (en) 2011-01-11 2020-02-25 Capsugel Belgium Nv Hard capsules
US11319566B2 (en) 2017-04-14 2022-05-03 Capsugel Belgium Nv Process for making pullulan
US11576870B2 (en) 2017-04-14 2023-02-14 Capsugel Belgium Nv Pullulan capsules
US11878079B2 (en) 2017-04-14 2024-01-23 Capsugel Belgium Nv Pullulan capsules

Also Published As

Publication number Publication date
JP5090431B2 (en) 2012-12-05

Similar Documents

Publication Publication Date Title
Wang et al. Two‐photon microscopy of deep intravital tissues and its merits in clinical research
Tochitsky et al. Restoring vision to the blind with chemical photoswitches
Shabahang et al. Light‐guiding biomaterials for biomedical applications
Maya-Vetencourt et al. A fully organic retinal prosthesis restores vision in a rat model of degenerative blindness
Dacey et al. Fireworks in the primate retina: in vitro photodynamics reveals diverse LGN-projecting ganglion cell types
Imanishi et al. Two-photon microscopy: shedding light on the chemistry of vision
US9486447B2 (en) Compositions and methods for controlling neuronal excitation
CN108330157A (en) Composition for detecting the biomembrane in living tissue
Mahendra et al. Detrimental Effects of UVB on Retinal Pigment Epithelial Cells and Its Role in Age‐Related Macular Degeneration
JP2004121292A (en) Receptor potential inducer
CN1678342A (en) Treatment for eye disorder
JP5090431B2 (en) Screening method for organic dye compounds for receptor potential inducers
WO2015062177A1 (en) Method for preparing heterogenous corneal material
Wright et al. Restoring vision in mice with retinal degeneration using multicharacteristic opsin
JP2020203923A (en) Nano-enhanced optical delivery of exogenous molecules to cells and tissues
Lerman An experimental and clinical evaluation of lens transparency and aging
CN105343933B (en) A kind of method and its application of photooxidation collagen cross-linking
Ghosh et al. Application of bioengineering in revamping human health
JP2008541798A (en) Ophthalmic instruments and methods
Isago et al. Establishment of monocular-limited photoreceptor degeneration models in rabbits
Matsuo et al. Safety, efficacy, and quality control of a photoelectric dye-based retinal prosthesis (Okayama University-type retinal prosthesis) as a medical device
CN105343934B (en) A kind of artificial cornea and preparation method thereof
CN109321629A (en) A kind of in-vitro method using the evaluation light injury of isolated cornea organ
Teh et al. In vivo optogenetics for light-induced oxidative stress in transgenic zebrafish expressing the KillerRed photosensitizer protein
Ramos et al. The use of confocal laser microscopy to analyze mouse retinal blood vessels

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091216

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120306

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20120511

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120507

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20120612

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20120612

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120612

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120904

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120912

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150921

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5090431

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20220921

Year of fee payment: 10

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees